FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Wegovy (semaglutide) from Novo Nordisk, supporting updated labeling or an expanded indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

SUPPL AP for WEGOVY (SEMAGLUTIDE)